With robust growth in medical technology it is beyond my grasp why we would ask the government to be making the decisions about what drugs a senior should have access to rather then promoting consumer choice.  This is simply another attempt by the Democrats to move America towards socialized medicine by asserting control over which drugs are available and at what price.  The current program, which encourages companies to compete for Medicare clients based on price and service, has proved to be far more effective in controlling prices and raising quality than even the most optimistic Republicans and think tanks predicted.